About
Chris Shanahan is a principal on the investment team at DFJ Growth, focusing on companies at the intersection of hardware and software—such as defensetech, autonomy, energy, robotics, and smart systems—as well as lifetech. He joined the firm in February 2018 and previously served as a DFJ Growth Fellow embedded at Neuralink in 2022. Before that, he was an analyst at Greenhill & Co. working on mergers and acquisitions and held R&D engineering roles at Boston Scientific's neuromodulation division and Johnson & Johnson's Acclarent division. He holds a bachelor of science with honors in biomedical engineering from Cal Poly.
Invests in
Defense TechEnergyHardwareRoboticsSpace Tech
Experience
- DFJ GrowthPrincipalcurrent2018 — presentSan Francisco Bay Area
- NeuralinkSpecial Projects2022San Francisco Bay Area
- Greenhill & Co.Investment Banking Analyst2016 — 2017San Francisco, California
- Greenhill & Co.Investment Banking Summer Analyst2015San Francisco, California
- Boston ScientificR&D Engineering Intern2014Valencia, CA
- AcclarentR&D Engineering Intern2013Menlo Park, CA
Education
- California Polytechnic State University-San Luis ObispoBS, Biomedical Engineering
- Freie Universität Berlin
Same school
Also attended California Polytechnic State University-San Luis Obispo57
+ 51 more
Also attended Freie Universität Berlin51
+ 45 more
Shared employers
Also worked at DFJ Growth14
+ 8 more
Also worked at Neuralink13
+ 7 more
Also worked at Greenhill & Co.38
+ 32 more
Also worked at Boston Scientific29
+ 23 more
Investments
Investor
CellanomeCellaresCommonwealth FusionGlowforgeHidden LevelNeocisNeuralinkNotCoParadigm HealthSaronicSpaceXVannevar LabsXxAI
Per the firm's website.








































